Back to Search
Journal ArticleOpen Access

Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Author Affiliations
McMaster University, Loyola University Medical Center, London School of Hygiene & Tropical Medicine, Simon Fraser University, ...
Published InThe Lancet Public Health
Year2017
Citations214

Abstract

BACKGROUND: Hypertension is considered the most important risk factor for cardiovascular diseases, but its control is poor worldwide. We aimed to assess the availability and affordability of blood pressure-lowering medicines, and the association with use of these medicines and blood pressure control in countries at varying levels of economic development. METHODS: We analysed the availability, costs, and affordability of blood pressure-lowering medicines with data recorded from 626 communities in 20 countries participating in the Prospective Urban Rural Epidemiological (PURE) study. Medicines were considered available if they were present in the local pharmacy when surveyed, and affordable if their combined cost was less than 20% of the households' capacity to pay. We related information about availability and affordability to use of…
View at Publisher

BORR does not host full-text PDFs. The button above takes you to the original publisher.